Uma Valeti, MD
516 Delaware St. SE, Clinic 4B
Minneapolis, MN 55455
Sees Patients at:
Philosophy of Care:I believe that patients approach their doctors with trust and respect and that this is a valuable relationship. I believe that all patients should have the best science available to them. I believe that the best science in combination with a commitment to clear clinical decision making, clinical judgment and communication is critical to deliver the most appropriate care.
SCCT, Annual meeting planning committee
Project title: “Apoptosis, myocyte loss and left ventricular remodeling in viable chronically dysfunctional myocardium” 2000, SUNY Buffalo
A research grant awarded to further the education of a young investigator in the field of Heart Diseases by the John C. Sable Memorial Heart Fund, Inc, Awarded for research on “Ischemic Cardiomyopathy and Hibernating Myocardium” 2000, SUNY Buffalo
2000-2001, Awarded by the University at Buffalo for research on “Ischemic Cardiomyopathy and Hibernating Myocardium”, 2000, SUNY-Buffalo
Certificate of Community Service presented by the Fire department of St. Paul and City of St. Paul for expert interventional care and compassionate care in patients with acute STEMIs, 2008
Very rapid treatment of ST-segment-elevation myocardial infarction: utilizing prehospital electrocardiograms to bypass the emergency department. Baran KW, Kamrowski KA, Westwater JJ, Tschida VH, Alexander CF, Beahrs MM, Biggs TA, Koller PT, Mahoney BD, Murray ST, Raya TE, Rusterholz PK, Valeti US, Wiberg TA. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):431-7.
Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. JACC Cardiovasc Imaging. 2010 Jan;3(1):52-60. Epub 2010 Jan 12.
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.Circ Heart Fail. 2010 Jan;3(1):51-8. Epub 2009 Oct 22.
Sorajja P, Valeti, US, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR Jr. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008 Jul 8;118(2):131-9
Valeti, US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy. J Am Coll Cardiol, 2007 Jan; 49:350-357, (Epub January 3,2007).
Valeti VU, Chun W, Potter DD, Araoz PA, McGee KP, Glockner JF, Christian TF. Myocardial tagging and strain analysis at 3 Tesla: comparison with 1.5 Tesla imaging. J Magn Reson Imaging. 2006 Apr;23(4):477-80.
Araoz PA, Glockner JF, McGee KP, Potter DD Jr, Valeti VU, Stanley DW, Christian TF. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson. 2005;7(3):559-64.
Holmes DR Jr, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv. 2005 Nov;66(3):375-89.
Valeti US, Miller TD, Hodge DO, Gibbons RJ. Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women. Circulation. 2005 Apr 12;111(14):1771-6. Epub 2005 Apr 4.
Gibbons RJ, Valeti US, Araoz PA, Jaffe AS. The quantification of infarct size. J Am Coll Cardiol. 2004 Oct 19;44(8):1533-42.